| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-30 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2024-01-02 |
|---|---|---|---|
| Revenue (Total Sales) | $3.75B | $3.58B | $3.44B |
| YoY Revenue Growth % | +4.7% | +4.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $187.3M | $178.3M | $108.6M |
| Operating Margin % | 5.0% | 5.0% | 3.2% |
| Net Income (GAAP) | $148.0M | $157.0M | $101.0M |
| EBITDA (Normalized) | $304.2M | $306.6M | $232.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $301.3M | $268.3M | $218.4M |
| Capital Expenditures (CapEx) | $146.2M | $160.4M | $154.8M |
| Free Cash Flow (FCF) | $155.1M | $108.0M | $63.6M |
| FCF Margin % | 4.1% | 3.0% | 1.8% |
| Return on Invested Capital (ROIC %) | 18.9% | 17.4% | 3.4% |
| Cash & Short-Term Equivalents | $215.7M | $84.2M | — |
| Total Debt (Short + Long Term) | $561.3M | $452.1M | $965.8M |
| Total Stockholders' Equity | $436.4M | $443.5M | $1.98B |